Viewing Study NCT05228158


Ignite Creation Date: 2025-12-25 @ 12:08 AM
Ignite Modification Date: 2026-01-01 @ 3:04 PM
Study NCT ID: NCT05228158
Status: RECRUITING
Last Update Posted: 2024-12-27
First Post: 2022-01-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in Japan
Sponsor: Eisai Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module